BioHarvest Sciences Inc.
BHST
$1.90
-$0.01-0.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 35.48M | 35.16M | 34.51M | 32.72M | 30.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.48M | 35.16M | 34.51M | 32.72M | 30.19M |
| Cost of Revenue | 14.56M | 14.24M | 14.03M | 13.35M | 12.67M |
| Gross Profit | 20.91M | 20.92M | 20.48M | 19.37M | 17.52M |
| SG&A Expenses | 21.51M | 21.15M | 20.74M | 20.10M | 19.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.86M | 40.85M | 40.08M | 38.86M | 37.52M |
| Operating Income | -6.38M | -5.69M | -5.58M | -6.14M | -7.32M |
| Income Before Tax | -10.98M | -11.35M | -11.06M | -11.74M | -11.98M |
| Income Tax Expenses | 97.00K | 84.00K | 76.00K | 148.00K | 85.00K |
| Earnings from Continuing Operations | -11.07 | -11.44 | -11.14 | -11.89 | -12.06 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.07M | -11.44M | -11.14M | -11.89M | -12.06M |
| EBIT | -6.38M | -5.69M | -5.58M | -6.14M | -7.32M |
| EBITDA | -4.96M | -4.35M | -4.27M | -4.84M | -6.05M |
| EPS Basic | -0.53 | -0.60 | -0.62 | -0.69 | -0.70 |
| Normalized Basic EPS | -0.33 | -0.37 | -0.38 | -0.42 | -0.43 |
| EPS Diluted | -0.53 | -0.60 | -0.62 | -0.69 | -0.70 |
| Normalized Diluted EPS | -0.33 | -0.37 | -0.38 | -0.42 | -0.43 |
| Average Basic Shares Outstanding | 84.14M | 78.80M | 73.46M | 69.42M | 69.33M |
| Average Diluted Shares Outstanding | 84.14M | 78.80M | 73.46M | 69.42M | 69.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |